Chief Marketing and Communications Officer
703.838.0033 ext. 393
February 28, 2019
10 Healthcare Organizations Commit to Further Advancing Type 2 Diabetes Care
Alexandria, VA – AMGA, with support from AMGA Foundation and Novo Nordisk Inc., announced the 10 organizations participating in its Together 2 Goal® (T2G) Diabetes Bundle Best Practices Learning Collaborative, an intensive learning collaborative meant to help T2G campaign enrollees improve the quality of care they deliver to patients with Type 2 diabetes. The participants will endeavor to improve outcomes on the T2G diabetes bundle measure which includes HbA1c control, blood pressure control, lipid management, medical attention for nephropathy.
The following AMGA member medical groups and health systems have been selected to participate in the collaborative:
- Summit Medical Group, Berkeley Heights, NJ
- Mercy East Communities, Washington, MO
- Valley Medical Group, Paramus, NJ
- Privia Health, Arlington, VA
- Norton Medical Group, Louisville, KY
- Ochsner Health System, New Orleans, LA
- Palo Alto Medical Foundation, Mountain View, CA
- Geisinger Health, Danville, PA
- Michigan Medicine, Ann Arbor, MI
- Excela Health, Greensburg, PA
“Like all of our T2G campaign participants, these 10 organizations are unremittingly committed to improving the way they care for patients with Type 2 diabetes,” said John Kennedy, M.D., AMGA chief medical officer and AMGA Foundation president. “AMGA collaboratives serve as catalysts for the free flow of ideas and discoveries, and the exchange of information, strategies, and support among groups with a shared mission can bring about substantive change. We look forward to helping these participants truly transform care for patients with diabetes.”
This collaborative is an expansion of AMGA’s recent six-month pilot initiative to improve outcomes on the T2G Core Track diabetes bundle measure. During the pilot, the rate of improvement for bundle measures among pilot groups was twice that of other groups participating in the T2G campaign.
The Diabetes Bundle Collaborative offers participating organizations an opportunity to expand their quality improvement work and accelerate their pace of improvement. It also will provide these 10 participants with access to peer organizations, an advisory committee of clinical experts, and AMGA staff to help improve their diabetes bundle measure as well as provide motivation and resources.
“We’re proud to partner with AMGA in improving medical care for people living with diabetes,” said Todd Hobbs, M.D., Novo Nordisk Inc. chief medical officer. “Quality care for patients living with diabetes is multidisciplinary and focuses on outcomes beyond glucose control, including appropriate management of lipids and blood pressure, and we’re excited to support these health systems’ collaboration to change the trajectory of diabetes in their communities.”
Participating organizations will meet in-person twice over the course of the collaborative and will attend bi-monthly educational webinars to discuss insights, plans, challenges, lessons learned, achievements, and new tools and resources. The first in-person meeting will occur in San Diego, CA, on May 8-9, 2019.
About the Together 2 Goal® Campaign
AMGA Foundation, the philanthropic arm of AMGA, launched Together 2 Goal®, a national campaign to fight the challenge of Type 2 diabetes on March 12, 2016. Together 2 Goal® includes more than 150 medical groups, health systems, nonprofit partners, and corporate collaborators such as the American Diabetes Association, American Association of Diabetes Educators, Novo Nordisk, Geisinger Health System, Henry Ford Health System, Intermountain Healthcare, and Ochsner Health System. The goal of the five-year campaign is to improve care for 1 million people with Type 2 diabetes by 2021.Learn more at together2goal.org.
About AMGA Foundation
AMGA Foundation is AMGA’s philanthropic arm that enables medical groups and other organized systems of care to consistently improve health and health care. AMGA Foundation serves as a catalyst, connector, and collaborator for translating the evidence of what works best in improving health and health care in everyday practice. Learn more at amga.org/foundation.
About Novo Nordisk
Novo Nordisk, a global healthcare company, has been committed to discovering and developing innovative medicines to help people living with diabetes lead longer, healthier lives for 95 years. This heritage has given us experience and capabilities that also enable us to help people defeat other serious diseases including obesity, hemophilia and growth disorders. We remain steadfast in our conviction that the formula for success is to stay focused, think long term and do business in a financially, socially and environmentally responsible way. With U.S. headquarters in New Jersey and production and research facilities in five states, Novo Nordisk employs nearly 6,000 people throughout the country. For more information, visit novonordisk.us, Facebook, Instagram and Twitter.
AMGA is a trade association leading the transformation of health care in America. Representing multispecialty medical groups and integrated systems of care, we advocate, educate, innovate and empower our members to deliver the next level of high performance health. AMGA is the national voice promoting awareness of medical groups’ recognized excellence in the delivery of coordinated, high-quality, cost-effective care. More than 175,000 physicians practice in our member organizations, delivering care to one in three Americans.